6416 studies found for:    breast,cancer,treatment
Show Display Options
Rank Status Study
1 Completed
Has Results
Understanding Shared Psychobiological Pathways
Condition: Breast Neoplasms
Interventions: Behavioral: Education;   Behavioral: Peer support
2 Recruiting A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Condition: Vaginal Atrophy
Interventions: Drug: estriol;   Drug: Placebo
3 Completed Stress Management in Breast Cancer Patients
Conditions: Breast Cancer;   Stress
Intervention: Behavioral: Stress management, in two steps
4 Recruiting Hula, a Physical Activity Intervention for Female-Cancer Survivors
Conditions: Physical Activity;   Breast Cancer;   Cervical Cancer;   Ovarian Cancer;   Endometrial Cancer
Intervention: Behavioral: Hula
5 Active, not recruiting Cognitive Changes Associated With Breast Cancer Treatment
Conditions: Breast Cancer;   Cognitive Side Effects of Cancer Treatments;   Stage I, II and III A Breast Cancer
Intervention: Behavioral: Questionnaires, MRI, Comet assay and Cell senescence
6 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
7 Completed Predictive Model of Therapy Outcomes in Breast Cancer Patients
Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Intervention:
8 Active, not recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Aromatase Inhibition Therapy;   Drug: Carboplatin;   Other: Cytology Specimen Collection Procedure;   Drug: Docetaxel;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation
9 Completed
Has Results
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Conditions: Breast Cancer;   Dermatologic Complications;   Radiation Toxicity;   Skin Reactions Secondary to Radiation Therapy
Interventions: Drug: mometasone furoate;   Other: placebo
10 Active, not recruiting Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation
Condition: Cancer of the Breast
Interventions: Procedure: Surgery for breast cancer;   Other: No Loco-regional treatment
11 Completed Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Conditions: Breast Cancer;   Cancer Survivor;   Fatigue;   Long-term Effects Secondary to Cancer Therapy in Adults;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Behavioral: exercise intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: survey administration;   Procedure: assessment of therapy complications;   Procedure: fatigue assessment and management;   Procedure: management of therapy complications;   Procedure: psychosocial assessment and care
12 Active, not recruiting Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Multi-Beam Intensity-Modulated Radiation Therapy
13 Recruiting PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Condition: Breast Cancer
Interventions: Drug: Neoadjuvant tamoxifen + goserelin (premenopausal women);   Drug: Neoadjuvant letrozole (postmenopausal women);   Drug: Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone);   Drug: Neoadjuvant docetaxel + cyclophosphamide;   Drug: Neoadjuvant docetaxel;   Drug: Neoadjuvant docetaxel + trastuzumab + pertuzumab;   Drug: Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab;   Drug: Neoadjuvant olaparib;   Drug: Neoadjuvant olaparib + carboplatin (if lack of response to olaparib alone);   Procedure: Breast conserving surgery or mastectomy + SNB/axillary dissection;   Radiation: Postoperative radiotherapy breast/chest wall + regional lymph nodes;   Drug: Adjuvant trastuzumab;   Drug: Adjuvant letrozole (postmenopausal women);   Drug: Adjuvant tamoxifen + goserelin (premenopausal women);   Drug: Adjuvant palbociclib (if palbociclib given neoadjuvant);   Drug: Adjuvant Epirubicin+ Cyclophosphamide
14 Recruiting Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
15 Not yet recruiting Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
Condition: Breast Cancer
Intervention: Radiation: Adjuvant Hypofractionated Radiation
16 Terminated Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: methotrexate;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Radiation: radiation therapy
17 Completed Breast Cancer With Over-expression of erbB2-BRAINSTORM
Condition: Cancer
Intervention: Drug: Anti-erbB2 therapy as part of a treatment regimen for either brain metastases or primary breast cancer
18 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
19 Completed Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Procedure: adjuvant therapy
20 Terminated Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Cardiac Toxicity;   Inflammatory Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Drug: paclitaxel;   Biological: trastuzumab;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: tamoxifen citrate;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years